SALMETEROL

SynDRA canonical compound SYN0004929 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRB2
Mechanism of action	Adrenergic receptor agonist
Indication	asthma \| bronchospasm \| chronic obstructive pulmonary disease (COPD)
Disease area	pulmonary

All known targets

serevent
salmeterol xinafoate
Salmaterol
GR-33343-X
SN408D
Aeromax
Astmerole
SALMATEROL
Salmeterolum
Serevent
Glaxo Wellcome brand of salmeterol xinafoate
Salmeterolum [Latin]
GR-33343X
S 2692
Serevent (TN)
Salmeterol (USAN/INN)
Salmeterol [USAN:BAN:INN]
(+-)-4-Hydroxy-alpha'-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol
(+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol
(inverted question mark) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol
2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol
2-(hydroxymethyl)-4-[1-hydroxy-2-({6-[(4-phenylbutyl)oxy]hexyl}amino)ethyl]phenol
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
2I4BC502BT
gr-33343x
DTXCID803571
Neovent
Soltel
RefChem:56523
CHEBI:9011
R03AC12
Arial
Beglan
NSC-272693
Salmetedur
salmeterolo
MFCD00867037
SMR000466295